In 2018, when Mike DeWine was Ohio’s attorney general, he began investigating an obscure corner of the health care industry. He believed that insurers were inflating prescription drug prices through management companies that operated as middlemen in the drug supply chain. There were concerns that these companies, known as pharmacy benefit managers, or PBMs, were fleecing agencies like Medicaid, the government-run health insurance program for the poor.
